{"ai_pass_count":4,"analysis_step_count":9,"confidence":0.8614144756325653,"created_at":"2026-08-09T02:07:13.184104+00:00","id":217333,"node_number":"683211","processing_time":1.7588355541229248,"recent_steps":["net.store_session","net.llm_structured_analysis","net.rules_detect","net.context_window","crawler.extract_candidates"],"recording_id":227641,"text":"the human cell and the same one targeted by conventional flu shot. And HA or hemocleutinin, you take fairly quick, which makes it a challenge for conventional vaccine to match the flu viruses. So 40,000 people participated in the study where around 970 became ill from the flu. The mRNA vaccine was 26.6 percent more protective potential vaccine against illness from the flu. And EMOCIVA gave superior protection against each of the three flu subtypes included in the vaccine. And participants 65 and up received 27.4 percent more protection overall, dropping. And the mRNA group developed more of the flu."}